HLB Pep Co., Ltd. (KOSDAQ:196300)
South Korea · Delayed Price · Currency is KRW 4,215.00
-45.00 (-1.06%)
At close: Sep 3, 2026
HLB Pep Market Cap
HLB Pep has a market cap or net worth of 40.74 billion as of September 4, 2026. Its market cap has decreased by -44.51% in one year.
Market Cap
40.74B
Enterprise Value
33.67B
Revenue
5.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,215.00
ChartMarket Cap Chart
Since December 7, 2016, HLB Pep's market cap has decreased from 59.66B to 40.74B, a decrease of -31.71%. That is a compound annual growth rate of -3.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 39.52B | -40.61% |
| Dec 30, 2025 | 66.54B | -5.59% |
| Dec 30, 2024 | 70.48B | -19.25% |
| Dec 28, 2023 | 87.28B | 110.23% |
| Dec 29, 2022 | 41.51B | -51.73% |
| Dec 30, 2021 | 86.00B | 24.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 7, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| J2KBIO | 59.70B |
| NovMetaPharma | 57.79B |
| KoBioLabs | 57.77B |
| QuadMedicine | 55.92B |
| CHOOLIP & SCIENCES | 53.56B |
| Parataxis Korea | 44.13B |
| Progen | 39.44B |
| Kainos Medicine | 35.56B |